Bausch Health Companies Inc
BHC
Company Profile
Business description
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Contact
2150 St Elzear Boulvard West
LavalQCH7L 4A8
CANT: +1 514 744-6792
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
20,700
Stocks News & Analysis
stocks
Palantir earnings: AI leadership intact; valuation still causes heartburn
Our view of Palantir Technologies.
stocks
As Nvidia crosses $5 trillion, 5 charts on the unstoppable tech rally
Demand for AI has catapulted tech stocks into the stratosphere.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,071.20 | 19.30 | -0.21% |
| CAC 40 | 8,073.00 | 5.47 | 0.07% |
| DAX 40 | 24,033.65 | 84.54 | 0.35% |
| Dow JONES (US) | 47,090.67 | 5.43 | 0.01% |
| FTSE 100 | 9,781.74 | 66.78 | 0.69% |
| HKSE | 25,935.41 | 16.99 | -0.07% |
| NASDAQ | 23,494.32 | 145.68 | 0.62% |
| Nikkei 225 | 50,212.27 | 1,284.93 | -2.50% |
| NZX 50 Index | 13,620.98 | 15.02 | 0.11% |
| S&P 500 | 6,794.68 | 23.13 | 0.34% |
| S&P/ASX 200 | 8,802.00 | 7.80 | -0.09% |
| SSE Composite Index | 3,969.25 | 9.06 | 0.23% |